Iterum Therapeutics(ITRMF)
$0.030.00 (0.00%)
ITRMF
Iterum Therapeutics earnings date
$0.03
At close:0.00 (0.00%)
Want to see ITRMF full AI Analyst Report?
Iterum Therapeutics (ITRMF) Earnings Dates, Call Summary & Reports
951 Followers
Earnings Data
- Report Date
- ―
- Period Ending
- ―
- Consensus EPS Forecast
- ―
- Last Year’s EPS
- ―
TBA (Not Confirmed)
Same Quarter Last Year
Iterum Therapeutics (ITRMF) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced.
ITRMF Q4 2025 Earnings Report
ITRMF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release | Slides | Play Transcript |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | 2026 (Q3) | ―- | -0.16 | ― | ― | ― | |
| Aug 07, 2026 | 2026 (Q2) | ―- | -0.13 | ― | ― | ― | |
| May 20, 2026 | 2026 (Q1) | ―- | -0.1 | ― | ― | ― | |
| Mar 12, 2026 | 2025 (Q4) | -0.14-0.20 | -0.12 | -66.67% (-0.08) | ― | ― | |
| Nov 14, 2025 | 2025 (Q3) | -0.09-0.16 | -0.24 | 33.33% (+0.08) | ― | ||
| Aug 05, 2025 | 2025 (Q2) | -0.11-0.13 | -0.23 | 43.48% (+0.10) | ― | ||
| May 13, 2025 | 2025 (Q1) | -0.14-0.10 | -0.38 | 73.68% (+0.28) | ― | ||
| Feb 07, 2025 | 2024 (Q4) | -0.17-0.12 | -0.81 | 85.19% (+0.69) | ― | ||
| Nov 14, 2024 | 2024 (Q3) | -0.17-0.24 | -1.2 | 80.00% (+0.96) | ― | ||
| Aug 14, 2024 | 2024 (Q2) | -0.45-0.23 | -0.77 | 70.13% (+0.54) | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous quarter.
Beat Missed
ITRMF Earnings-Related Price Changes
| Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 12, 2026 | $0.03 | $0.03 | +0.00% |
| Aug 07, 2026 | $0.03 | $0.03 | +0.00% |
| May 20, 2026 | $0.03 | $0.04 | +33.33% |
| Mar 12, 2026 | $0.17 | $0.17 | +0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after its recent earnings reports.

